CorMedix Inc
CRMD
Get informed when a big investor buys or sells
+ FollowMarket Cap$662.13M
Close$
$-0.37
104.5% downside
Current Fair Value
104.5% downsideOvervalued by 104.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $662.13 Million |
|---|---|
| Enterprise Value | $628.93 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $2.25 |
| Beta | 1.46 |
| Outstanding Shares | 79,509,000 |
Return
| Return on Equity | 24856.58% |
|---|---|
| Return on Assets | 13319.09% |
| Return on Invested Capital | 7812.94% |
Valuation & Multiples
| P/E Ratio | 3.71 |
|---|---|
| PEG | 4.26 |
| Price to Sales | 0.01 |
| Price to Book Ratio | 1.65 |
| Enterprise Value to Revenue | 0.01 |
| Enterprise Value to EBIT | 0.01 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0.23 |
| Debt to Equity | 0.33 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$0.35
Average shareholder expectationRevenue Estimate
$104.96 M
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$0.26
Average shareholder expectationRevenue Estimate
$94.95 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.1130▲ 44.71% |
|---|---|
| Total Calls | 1,649,500▼ 20.23% |
| Total Puts | 1,835,927▲ 33.32% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 56.29%▲ 1.03% |
|---|---|
| Total Invested | $275.62M▼ 43.51% |
| Investors Holding | 198▼ 12.00% |
ESG Score
No data
About CorMedix Inc
CEO: Khoso Baluch